Skip to content

Dabigatran Etexilate Mesylate

Generic Medicine With 11 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Dabigatran Etexilate Mesylate

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

Stroke Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation: Dabigatran Etexilate Mesylate is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Treatment of Deep Venous Thrombosis and Pulmonary Embolism ... Read more Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation: Dabigatran Etexilate Mesylate is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Treatment of Deep Venous Thrombosis and Pulmonary Embolism: Dabigatran Etexilate Mesylate is indicated for the treatment of deep venous thrombosis and pulmonary embolism in patients who have been treated with a parenteral anticoagulant for 5-10 days. Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism: Dabigatran Etexilate Mesylate is indicated to reduce the risk of recurrence of deep venous thrombosis and pulmonary embolism in patients who have been previously treated. Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism Following Hip Replacement Surgery: Dabigatran Etexilate Mesylate is indicated for the prophylaxis of deep vein thrombosis and pulmonary embolism, in patients who have undergone hip replacement surgery.

Dosage And Administration

Reduction in Risk of Stroke and Systemic Embolism in Non-valvular AF- CrCl >30 mL/min: 150 mg twice daily CrCl 15 to 30 mL/min: 75 mg twice daily CrCl 30 mL/min, the recommended dose of Dabigatran Etexilate is 150 mg taken orally, twice daily after previous treatment. Dosing recommendations for patients with a CrCl ≤30 mL/min or on dialysis cannot be provided. Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism Following Hip Replacement Surgery: For patients with CrCl >30 mL/min, the recommended dose of Dabigatran Etexilate is 110 mg taken orally 1-4 hours after surgery and after hemostasis has been achieved, then 220 mg taken once daily for 28-35 days. If Dabigatran Etexilate is not started on the day of surgery, after hemostasis has been achieved initiate treatment with 220 mg once daily. Dosing recommendations for patients with a CrCl ≤30 mL/min or on dialysis cannot be provided

Side Effects

The following clinically significant adverse reactions are described elsewhere in the labeling: Increased Risk of Thrombotic Events after Premature Discontinuation Risk of Bleeding Spinal/Epidural Anesthesia or Puncture Thromboembolic and Bleeding Events in Patients with Prosthetic Heart Valves Increased Risk of Thrombosis in Patients with Triple-Positive Antiphospholipid Syndrome

Precautions And Warnings

Bleeding: Dabigatran Etexilate can cause serious and fatal bleeding Bioprosthetic heart valves: Dabigatran Etexilate use not recommended Increased Risk of Thrombosis in Patients with Triple-Positive Antiphospholipid Syndrome: Dabigatran Etexilate use not recommended

Pregnancy And Lactation

Pregnancy: The limited available data on Dabigatran Etexilate use in pregnant women are insufficient to determine drug-associated risks for adverse developmental outcomes. There are risks to the mother associated with untreated venous thromboembolism in pregnancy and a risk of hemorrhage in the mother and fetus associated with the use of anticoagulant Lactation: There are no data on the presence of dabigatran in human milk, the effects on the breastfed child, or on milk production. Dabigatran and/or its metabolites were present in rat milk. Breastfeeding is not recommended during treatment with Dabigatran Etexilate.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 11

Sorted By
Capsule

Dabigat 75 mg

Generic: Dabigatran Etexilate Mesylate

75.00Taka / Unit

View Medicine
Capsule

Dabigat 110 mg

Generic: Dabigatran Etexilate Mesylate

95.00Taka / Unit

View Medicine
Capsule

Dabigat 150 mg

Generic: Dabigatran Etexilate Mesylate

130.00Taka / Unit

View Medicine
Capsule

Dabiran 75 mg

Generic: Dabigatran Etexilate Mesylate

75.00Taka / Unit

View Medicine
Capsule

Dabiran 110 mg

Generic: Dabigatran Etexilate Mesylate

95.00Taka / Unit

View Medicine
Capsule

Dabiran 150 mg

Generic: Dabigatran Etexilate Mesylate

95.00Taka / Unit

View Medicine
Capsule

Dabiren 150 mg

Generic: Dabigatran Etexilate Mesylate

95.00Taka / Unit

View Medicine
Capsule

Dabixta 110 mg

Generic: Dabigatran Etexilate Mesylate

95.00Taka / Unit

View Medicine
Capsule

Dabixta 75 mg

Generic: Dabigatran Etexilate Mesylate

75.00Taka / Unit

View Medicine
Capsule

Pradaxa 150 mg

Generic: Dabigatran Etexilate Mesylate

95.00Taka / Unit

View Medicine
Capsule

Pradaxa 110 mg

Generic: Dabigatran Etexilate Mesylate

95.00Taka / Unit

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250